COMMUNIQUÉS West-GlobeNewswire

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
27/02/2026
WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) [...]
FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
27/02/2026
The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing interval Commercial availability expected during early part of Q2 2026 Rare Pediatric Disease [...]
Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference
27/02/2026
WESTLAKE VILLAGE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
27/02/2026
Strong cash position at year-end 2025: $33.3 million (€28.4 million) CNS (Vafidemstat) Appointed renowned Rolando Gutierrez-Esteinou, M.D. as new CMO for CNS Preparing protocol resubmission to incorporate FDA guidance [...]
AshtonManual.org Launches as the Definitive Resource for Safe, Evidence-Based Benzodiazepine Tapering
27/02/2026
New Educational Platform Brings the Gold Standard of Benzodiazepine Withdrawal Guidance to Patients and Families, Backed by the Clinical Expertise of Dr. Mark Leeds, D.O. Fort Lauderdale, FL, Feb. 27, 2026 (GLOBE [...]
Disclosure of a transparency notification from AOC Pharma S.à r.l.
27/02/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure [...]
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States
27/02/2026
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States Irving, Texas, USA – February 27, 2026 – Atos , a global leader in AI-powered digital transformation, today [...]
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
27/02/2026
CRANFORD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“ Enzon ” or the “ Company ”) today announced that it has extended the expiration date for the exchange offer by the Company [...]
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
27/02/2026
After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to Achieve Near-term [...]
OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry
27/02/2026
MINNEAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today [...]
New Study Finds Half of Americans Don’t Know You Can Screen for Colorectal Cancer at Home
27/02/2026
Knowledge Gaps and Dismissed Symptoms May Contribute to Rising Deaths in Younger Adults WASHINGTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Colorectal cancer is now the leading cause of cancer-related death among adults under [...]
Certara to Participate in Upcoming Investor Conferences
27/02/2026
RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor [...]
Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders
27/02/2026
PARAMUS, NJ, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“ [...]
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
27/02/2026
OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead [...]
The Standard Process Brand Evolution Elevates Awareness of Whole Food Nutrition
27/02/2026
The company’s 97-year commitment to restore nutritional integrity as the foundation of health A Media Snippet accompanying this announcement is available by clicking on this link. PALMYRA, Wis., Feb. 27, 2026 (GLOBE [...]
Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting
27/02/2026
Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or dose-limiting toxicities at three months Early signals of functional and structural improvement [...]
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum
27/02/2026
Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device Over 700 RenovoCath Procedures Successfully Completed Since FDA [...]
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
27/02/2026
Adds Avidity’s differentiated muscle-directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-stage programs to industry-leading neuromuscular pipeline Potentially unlocks multi-billion-dollar [...]
Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts
27/02/2026
The Global Alzheimer’s Platform Foundation’s® (GAP) 2025 Citizen Scientist Award® recipients announced in Las Vegas WASHINGTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Today, the Global Alzheimer’s Platform Foundation (GAP) [...]

Pages